Literature DB >> 1195454

Effect of trimethoprim-sulfamethoxazole on the renal excretion of creatinine in man.

F Berglund, J Killander, R Pompeius.   

Abstract

Treatment with the chemotherapeutic combination of 160 mg. trimethoprim plus 800 mg. sulfamethoxazole twice daily increased the serum creatinine level by an average of 2 mg. per 1. in 21 patients. The effect was clearly reversible. The chemical analysis of creatinine was not affected by the addition of trimethoprim, sulfamethoxazole or their metabolites. In 2 subjects given the drug combination for 12 days renal excretion and 24-hour clearances of creatinine decreased but iothalamate 131I clearance was unchanged. Consequently, the rise in serum creatinine does not indicate any decrease in the glomerular filtration rate. The serum creatinine started to rise within 4 hours after oral administration of a single dose. The rise in serum creatinine could be produced with trimethoprim alone but not with sulfamethoxazole alone. When the plasma creatinine was raised to 100 mg. per l. in healthy subjects (by giving creatinine orally), trimethoprim increased the creatinine levels 10 times as much as at normal plasma levels. The effect was interpreted as a competitive inhibition of the mechanism for tubular secretion of creatinine through the base-secreting pathway.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1195454     DOI: 10.1016/s0022-5347(17)67149-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  39 in total

1.  Trimethoprim- sulfamethoxazole: pharmacokinetics, clinical uses, and adverse reactions.

Authors:  M A Kielhofner
Journal:  Tex Heart Inst J       Date:  1990

2.  Iothalamate versus estimated GFR in a Hispanic-dominant pediatric renal transplant population.

Authors:  Karen E Papez; Gina-Marie Barletta; Stephanie Hsieh; Mark Joseph; Bruce Z Morgenstern
Journal:  Pediatr Nephrol       Date:  2013-12       Impact factor: 3.714

Review 3.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

4.  Effects of moderate-dose versus high-dose trimethoprim on serum creatinine and creatinine clearance and adverse reactions.

Authors:  O Naderer; A N Nafziger; J S Bertino
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

Review 5.  Estimating glomerular filtration rate in kidney transplantation: Still searching for the best marker.

Authors:  Josefina Santos; La Salete Martins
Journal:  World J Nephrol       Date:  2015-07-06

Review 6.  Measurement of renal function in patients with chronic kidney disease.

Authors:  Euan A Sandilands; Neeraj Dhaun; James W Dear; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

Review 7.  Trimethoprim-induced hyperkalaemia: clinical data, mechanism, prevention and management.

Authors:  M A Perazella
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

8.  The effect of co-trimoxazole on serum creatinine.

Authors:  B A Dijkmans; J P van Hooff; F A de Wolff; H Mattie
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

9.  Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).

Authors:  R B Patel; P G Welling
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

10.  [Effect of Co-trimoxazole on renal creatinine excretion in man (author's transl)].

Authors:  M Bräutigam; P Froese; R Baethke; M Kessel
Journal:  Klin Wochenschr       Date:  1979-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.